A phase II study of vorinostat and rituximab for treatment of newly diagnosed and relapsed/refractory indolent non-Hodgkin lymphoma oleh Robert Chen, Paul Frankel, Leslie Popplewell, Tanya Siddiqi, Nora Ruel, Arnold Rotter, Sandra H. Thomas, Michelle Mott, Nitya Nathwani, Myo Htut, Auayporn Nademanee, Stephen J. Forman, Mark Kirschbaum